Nuevos anticoagulantes orales en poblaciones especiales
2016
The new oral anticoagulants are now a reality and are available to clinicians. Although a large number of patients have been included in the many clinical trials of these drugs, there is one population that is always underrepresented - called special populations – such as those aged more than 75 years old, the obese, and patients with renal impairment. This review aims to analyze differences in the efficacy and safety in these special populations recruited in the various trials.
- Correction
- Cite
- Save
- Machine Reading By IdeaReader
20
References
0
Citations
NaN
KQI